Greenwich Associates
3
5M
3
0.06
2
- Areas of investment
Summary
Greenwich Associates appeared to be the Corporate Investor, which was created in 1972. The leading representative office of defined Corporate Investor is situated in the Stamford. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Storm Ventures, Kevin Rose, Jay Adelson. In the next rounds fund is usually obtained by Canaan Partners, Storm Ventures.
The top activity for fund was in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year.
Among the most popular fund investment industries, there are Cloud Data Services, Enterprise Software. Among the various public portfolio startups of the fund, we may underline 3Crowd Technologies For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.06
- Investments by industry
- Cloud Data Services (1)
- Content Creators (1)
- Enterprise Software (1)
- Food and Beverage (1)
- Manufacturing (1) Show 7 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2009
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 1.00
- Avg. company exit year
- 17
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Forbes Medi-Tech | 07 Jan 2004 | Biotechnology, Health Care, Life Science, Nutrition, Dietary Supplements | Early Stage Venture | 10M | United States, New Jersey |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.